Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans

Journal of Pain

Volumn 1, Issue 2, 2000, Pages 122-127

  Gear, Robert W ^a,b   Miaskowski, Christine ^a,b   Gordon, Newton C ^a,b   Paul, Steven M ^a,b   Heller, Philip H ^a,b   Levine, Jon D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER FOUNDATION HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Females; Gender; Hyperalgesia; Males; Pain; Opioid

Indexed keywords

KAPPA OPIATE RECEPTOR; NALBUPHINE; NALOXONE;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HYPERALGESIA; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PAIN THRESHOLD; POSTOPERATIVE PAIN; SEX DIFFERENCE;

EID: 0033899996     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-5900(00)90097-X     Document Type: Article

References (28)

1. Opioid analgesics and antagonists
2. Enhancement of morphine analgesia by the GABA(B) agonist baclofen
3. Gender difference in analgesic response to the kappa-opioid pentazocine
4. Significantly greater analgesia in females compared to males after kappa-opioids
5. The kappa opioid nalbuphine produces gender and dose dependent analgesia and antianalgesia in patients with postoperative pain
6. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance
7. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices
8. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration
9. Antagonistic effects of the selective, competitive N-methyl-D-aspartate NMDA receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice
10. Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors
11. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers
12. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans
13. Influence of the method of drug administration on analgesic response
14. Potentiation of pentazocine analgesia by low-dose naloxone
15. A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat
16. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain
17. Kappa-Opioid receptor binding populations in rhesus monkey brain: Relationship to an assay of thermal antinociception
18. Intracerebroventricular physostigmine-induced analgesia: Enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A 1-17
19. Spinal dynorphin A 1:17: Possible mediator of antianalgesic action
20. Kappa opioid receptors participate in nerve growth factor-induced hyperalgesia
21. Cellular mechanism for antianalgesic action of agonists of the kappa-opioid receptor
22. A review of the role of antiopioid peptides in morphine tolerance and dependence
23. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla
24. Sex differences in N-methyl-D-aspartate involvement in kappa opioid and nonopioid predator-induced analgesia in mice
25. Spinal cord mediation of the opioid analgesia of pregnancy
26. Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: Effects of intrathecal norbinaltorphimine, a kappa-selective antagonist
27. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms
28. Differences in postoperative pain severity among four ethnic groups